Drug intelligence / Profile preview

phytonadione

Development stage
Unknown
Lead developer
Sunny Pharmtech
Modality
Small Molecules
Administration
Intramuscular, Subcutaneous, Intravenous
01

Overview

SP-010 is a generic injectable formulation of phytonadione (Vitamin K1) developed by Sunny Pharmtech. As a fat-soluble vitamin, phytonadione serves as an essential cofactor for the microsomal enzyme gamma-glutamyl carboxylase. This enzyme is responsible for the post-translational carboxylation of glutamate residues on vitamin K-dependent coagulation factors, including Factor II (prothrombin), VII, IX, and X, as well as protein C and protein S. This process is critical for the ability of these proteins to bind calcium and participate in the coagulation cascade. SP-010 is indicated for the treatment of hypoprothrombinemia caused by vitamin K deficiency, malabsorption, or anticoagulant therapy, and for the prevention of hemorrhagic disease in neonates.

Other names
Vitamin K1phylloquinonephytomenadione
02

Targets

VKORC1 (Vitamin K epoxide reductase complex subunit 1)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)

Beyond the preview

Go deeper on phytonadione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phytonadione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call